FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280490218> ?p ?o ?g. }

• W4280490218 endingPage "2091" @default.
• W4280490218 startingPage "2091" @default.
• W4280490218 abstract "Nutritional assessment is important for predicting a prognosis in hepatocellular carcinoma (HCC). The authors examined the utility of the recently developed neo-Glasgow prognostic score (GPS) as a nutritional prognostic assessment in HCC in a multicenter retrospective study of 271 patients with HCC and Child-Pugh class A liver function who underwent R0 resection between 2011 and 2013. The median age was 72 years, 229 and 42 patients had Child-Pugh scores of 5 and 6, respectively, 223 patients had single tumors, the median tumor size was 3.6 cm, and open and laparoscopic resection were performed in 138 and 133 patients, respectively. We compared the prognostic predictive utility of the prognostic nutritional index, neutrophil/lymphocyte and platelet/lymphocyte ratios, controlling nutritional status score, GPS, and neo-GPS, which uses albumin-bilirubin grade (ALBI) instead of albumin. The c-indexes for the predictive prognostic value for overall survival (OS) and progression-free survival (PFS) were best for neo-GPS (OS: 0.571 vs. ≤0.555; PFS: 0.555 vs. ≤0.546). In multivariate analysis with the Cox proportional hazards model, elevated alpha-fetoprotein (AFP; ≥100 ng/mL; hazard ratio [HR] 2.190, 95% confidence interval [CI] 1.493−3.211, p < 0.001), multiple tumors (HR 1.784, 95%CI 1.178−2.703, p = 0.006), tumor size of ≥5 cm (HR 1.508, 95%CI 1.037−2.193, p = 0.032), and neo-GPS of ≥1 (HR 1.554, 95%CI 1.074−2.247, p = 0.019) were significant prognostic factors for OS, whereas elevated AFP (≥100 ng/mL) (HR 1.743, 95%CI 1.325−2.292, p < 0.001), multiple tumors (HR 1.537, 95%CI 1.148−2.057, p = 0.004), and neo-GPS of ≥1 (HR 1.522, 95%CI 1.186−1.954, p = 0.001) were significant prognostic factors for PFS. A neo-GPS of ≥1 was associated with a higher rate of high-grade (≥3) Clavien-Dindo complications than a neo-GPS of <1 (31.1% vs. 17.0%, p = 0.007). Neo-GPS was a good prognostic nutritional assessment tool for the prediction of postoperative complications and prognosis in patients undergoing surgical HCC resection." @default.
• W4280490218 created "2022-05-22" @default.
• W4280490218 creator A5018859016 @default.
• W4280490218 creator A5037231478 @default.
• W4280490218 creator A5040485741 @default.
• W4280490218 creator A5043799958 @default.
• W4280490218 creator A5046365684 @default.
• W4280490218 creator A5053874442 @default.
• W4280490218 creator A5064418329 @default.
• W4280490218 creator A5071857989 @default.
• W4280490218 creator A5086132249 @default.
• W4280490218 date "2022-04-22" @default.
• W4280490218 modified "2023-09-25" @default.
• W4280490218 title "Comparison of the New Neo-Glasgow Prognostic Score Based on the Albumin-Bilirubin Grade with Currently Used Nutritional Indices for Prognostic Prediction following Surgical Resection of Hepatocellular Carcinoma: A Multicenter Retrospective Study in Japan" @default.
• W4280490218 cites W1918799129 @default.
• W4280490218 cites W1963697247 @default.
• W4280490218 cites W1970902949 @default.
• W4280490218 cites W1991431093 @default.
• W4280490218 cites W2017352677 @default.
• W4280490218 cites W2023362970 @default.
• W4280490218 cites W2060123467 @default.
• W4280490218 cites W2062042802 @default.
• W4280490218 cites W2094703627 @default.
• W4280490218 cites W2096998881 @default.
• W4280490218 cites W2119190881 @default.
• W4280490218 cites W2121960517 @default.
• W4280490218 cites W2139880626 @default.
• W4280490218 cites W2192368460 @default.
• W4280490218 cites W2200286273 @default.
• W4280490218 cites W2406223713 @default.
• W4280490218 cites W2493051678 @default.
• W4280490218 cites W2591717879 @default.
• W4280490218 cites W2758905766 @default.
• W4280490218 cites W2774699776 @default.
• W4280490218 cites W2963303825 @default.
• W4280490218 cites W3125073715 @default.
• W4280490218 cites W3159503429 @default.
• W4280490218 cites W3177627853 @default.
• W4280490218 cites W3182634221 @default.
• W4280490218 cites W4220870243 @default.
• W4280490218 cites W4292405063 @default.
• W4280490218 cites W58571634 @default.
• W4280490218 cites W88960155 @default.
• W4280490218 doi "https://doi.org/10.3390/cancers14092091" @default.
• W4280490218 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35565221" @default.
• W4280490218 hasPublicationYear "2022" @default.
• W4280490218 type Work @default.
• W4280490218 citedByCount "2" @default.
• W4280490218 countsByYear W42804902182022 @default.
• W4280490218 countsByYear W42804902182023 @default.
• W4280490218 crossrefType "journal-article" @default.
• W4280490218 hasAuthorship W4280490218A5018859016 @default.
• W4280490218 hasAuthorship W4280490218A5037231478 @default.
• W4280490218 hasAuthorship W4280490218A5040485741 @default.
• W4280490218 hasAuthorship W4280490218A5043799958 @default.
• W4280490218 hasAuthorship W4280490218A5046365684 @default.
• W4280490218 hasAuthorship W4280490218A5053874442 @default.
• W4280490218 hasAuthorship W4280490218A5064418329 @default.
• W4280490218 hasAuthorship W4280490218A5071857989 @default.
• W4280490218 hasAuthorship W4280490218A5086132249 @default.
• W4280490218 hasBestOaLocation W42804902181 @default.
• W4280490218 hasConcept C126322002 @default.
• W4280490218 hasConcept C143998085 @default.
• W4280490218 hasConcept C167135981 @default.
• W4280490218 hasConcept C207103383 @default.
• W4280490218 hasConcept C2778019345 @default.
• W4280490218 hasConcept C38180746 @default.
• W4280490218 hasConcept C44249647 @default.
• W4280490218 hasConcept C50382708 @default.
• W4280490218 hasConcept C71924100 @default.
• W4280490218 hasConcept C90924648 @default.
• W4280490218 hasConceptScore W4280490218C126322002 @default.
• W4280490218 hasConceptScore W4280490218C143998085 @default.
• W4280490218 hasConceptScore W4280490218C167135981 @default.
• W4280490218 hasConceptScore W4280490218C207103383 @default.
• W4280490218 hasConceptScore W4280490218C2778019345 @default.
• W4280490218 hasConceptScore W4280490218C38180746 @default.
• W4280490218 hasConceptScore W4280490218C44249647 @default.
• W4280490218 hasConceptScore W4280490218C50382708 @default.
• W4280490218 hasConceptScore W4280490218C71924100 @default.
• W4280490218 hasConceptScore W4280490218C90924648 @default.
• W4280490218 hasIssue "9" @default.
• W4280490218 hasLocation W42804902181 @default.
• W4280490218 hasLocation W42804902182 @default.
• W4280490218 hasLocation W42804902183 @default.
• W4280490218 hasOpenAccess W4280490218 @default.
• W4280490218 hasPrimaryLocation W42804902181 @default.
• W4280490218 hasRelatedWork W1727188710 @default.
• W4280490218 hasRelatedWork W1975434185 @default.
• W4280490218 hasRelatedWork W2119154902 @default.
• W4280490218 hasRelatedWork W2133235702 @default.
• W4280490218 hasRelatedWork W2135028155 @default.
• W4280490218 hasRelatedWork W2203903734 @default.
• W4280490218 hasRelatedWork W2917746345 @default.
• W4280490218 hasRelatedWork W3181561567 @default.
• W4280490218 hasRelatedWork W4376871959 @default.
• W4280490218 hasRelatedWork W4384497977 @default.
• W4280490218 hasVolume "14" @default.

• next